Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions

E. Vízi, Balazs Lendvai

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Since acetylcholine (ACh) is the 'master key' to different subtypes of nicotinic and muscarinic receptors, and muscle relaxants (MRs) available in clinical practice are structurally related to it, MRs may exert their unwanted effects through inhibition of these receptors. Since the subunit composition of nicotinic ACh receptors (nAChRs) of pre- and/or postsynaptic location and the binding potency of MRs to these and muscarinic receptors are different, a search for selective muscle nAChR antagonists without or with less side effects seems to be promising and important for clinical practice.

Original languageEnglish
Pages (from-to)75-89
Number of pages15
JournalPharmacology and Therapeutics
Volume73
Issue number2
DOIs
Publication statusPublished - 1997

Fingerprint

Muscarinic Antagonists
Muscles
Nicotinic Receptors
Muscarinic Receptors
Acetylcholine

Keywords

  • antimuscarinic, antinicotinic, presynaptic effects
  • muscle relaxants
  • side effects
  • subunit composition

ASJC Scopus subject areas

  • Pharmacology

Cite this

Side effects of nondepolarizing muscle relaxants : Relationship to their antinicotinic and antimuscarinic actions. / Vízi, E.; Lendvai, Balazs.

In: Pharmacology and Therapeutics, Vol. 73, No. 2, 1997, p. 75-89.

Research output: Contribution to journalArticle

@article{8c386d0b3b064424b45dfb4e7fb4750a,
title = "Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions",
abstract = "Since acetylcholine (ACh) is the 'master key' to different subtypes of nicotinic and muscarinic receptors, and muscle relaxants (MRs) available in clinical practice are structurally related to it, MRs may exert their unwanted effects through inhibition of these receptors. Since the subunit composition of nicotinic ACh receptors (nAChRs) of pre- and/or postsynaptic location and the binding potency of MRs to these and muscarinic receptors are different, a search for selective muscle nAChR antagonists without or with less side effects seems to be promising and important for clinical practice.",
keywords = "antimuscarinic, antinicotinic, presynaptic effects, muscle relaxants, side effects, subunit composition",
author = "E. V{\'i}zi and Balazs Lendvai",
year = "1997",
doi = "10.1016/S0163-7258(96)00139-8",
language = "English",
volume = "73",
pages = "75--89",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Side effects of nondepolarizing muscle relaxants

T2 - Relationship to their antinicotinic and antimuscarinic actions

AU - Vízi, E.

AU - Lendvai, Balazs

PY - 1997

Y1 - 1997

N2 - Since acetylcholine (ACh) is the 'master key' to different subtypes of nicotinic and muscarinic receptors, and muscle relaxants (MRs) available in clinical practice are structurally related to it, MRs may exert their unwanted effects through inhibition of these receptors. Since the subunit composition of nicotinic ACh receptors (nAChRs) of pre- and/or postsynaptic location and the binding potency of MRs to these and muscarinic receptors are different, a search for selective muscle nAChR antagonists without or with less side effects seems to be promising and important for clinical practice.

AB - Since acetylcholine (ACh) is the 'master key' to different subtypes of nicotinic and muscarinic receptors, and muscle relaxants (MRs) available in clinical practice are structurally related to it, MRs may exert their unwanted effects through inhibition of these receptors. Since the subunit composition of nicotinic ACh receptors (nAChRs) of pre- and/or postsynaptic location and the binding potency of MRs to these and muscarinic receptors are different, a search for selective muscle nAChR antagonists without or with less side effects seems to be promising and important for clinical practice.

KW - antimuscarinic, antinicotinic, presynaptic effects

KW - muscle relaxants

KW - side effects

KW - subunit composition

UR - http://www.scopus.com/inward/record.url?scp=0030932243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030932243&partnerID=8YFLogxK

U2 - 10.1016/S0163-7258(96)00139-8

DO - 10.1016/S0163-7258(96)00139-8

M3 - Article

C2 - 9131719

AN - SCOPUS:0030932243

VL - 73

SP - 75

EP - 89

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -